# A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder

> **NCT00236379** · PHASE4 · COMPLETED · sponsor: **Janssen, LP** · enrollment: 59 (actual)

## Conditions studied

- Schizophrenia
- Diabetes Mellitus

## Interventions

- **DRUG:** Olanzapine
- **DRUG:** Risperidone

## Key facts

- **NCT ID:** NCT00236379
- **Lead sponsor:** Janssen, LP
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2003-08
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2011-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00236379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00236379, "A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00236379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*